• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Insulet Corporation - Common Stock (NQ:PODD)

    166.38 +0.70 (+0.42%)
    Streaming Delayed Price Updated: 3:17 PM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Insulet Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    News headline image
    1 Healthcare Stock to Target This Week and 2 We Brush Off
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
    Via StockStory
    Insulet Corp (NASDAQ:PODD): A Quality Affordable Growth Stock With Strong Earnings Momentum ↗
    Via Chartmill
    News headline image
    3 Quality Compounders on Our Buy List
    Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that genera... 
    Via StockStory
    Which S&P500 stocks are gapping on Monday? ↗
    Via Chartmill
    Insulet Corp (NASDAQ:PODD): Strong Growth Stock Consolidating Near Resistance for a Potential Breakout ↗
    Via Chartmill
    News headline image
    Patient Monitoring Stocks Q1 Earnings Review: Insulet (NASDAQ:PODD) Shines
    As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including... 
    Via StockStory
    Topics Artificial Intelligence
    INSULET CORP (NASDAQ:PODD) Fits the Affordable Growth Mold with Strong Momentum and Reasonable Valuation ↗
    Via Chartmill
    What's going on in today's after hours session: S&P500 movers ↗
    Via Chartmill
    News headline image
    1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
    The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
    Via StockStory
    News headline image
    1 Mid-Cap Stock Worth Your Attention and 2 We Question
    Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
    Via StockStory
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
    The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
    Via StockStory
    Topics Stocks
    Top S&P500 movers in Tuesday's session ↗
    Via Chartmill
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    Stay informed with the top movers within the S&P500 index on Friday. ↗
    Via Chartmill
    Which S&P500 stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
    DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out? 
    Via The Motley Fool
    News headline image
    3 Reasons We’re Fans of Insulet (PODD)
    Shareholders of Insulet would probably like to forget the past six months even happened. The stock dropped 54.4% and now trades at $144.10. This might have i... 
    Via StockStory
    News headline image
    Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
    Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States. 
    Via The Motley Fool
    Topics Regulatory Compliance
    Discover which S&P500 stocks are making waves on Thursday. ↗
    Via Chartmill
    Which S&P500 stocks are moving on Wednesday? ↗
    Via Chartmill
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    Gapping S&P500 stocks in Wednesday's session ↗
    Via Chartmill
    These S&P500 stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    1 Oversold Stock Set for a Comeback and 2 That Underwhelm
    The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
    Via StockStory
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings Call
    Insulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery system across both U.S. and inter... 
    Via StockStory
    Topics Earnings
    News headline image
    Why Insulet (PODD) Stock Is Trading Up Today
    What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage o... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    3 Quality Compounders to Research Further
    Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
    Via StockStory
    Which S&P500 stocks are moving on Thursday? ↗
    Via Chartmill
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.